KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Teva Pharmaceutical Industries (TEVA) Assets Average (2016 - 2025)

Teva Pharmaceutical Industries (TEVA) has disclosed Assets Average for 16 consecutive years, with $40.3 billion as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Assets Average fell 0.59% year-over-year to $40.3 billion, compared with a TTM value of $40.3 billion through Dec 2025, down 0.59%, and an annual FY2025 reading of $40.0 billion, down 3.3% over the prior year.
  • Assets Average was $40.3 billion for Q4 2025 at Teva Pharmaceutical Industries, up from $40.0 billion in the prior quarter.
  • Across five years, Assets Average topped out at $49.8 billion in Q1 2021 and bottomed at $38.9 billion in Q1 2025.
  • Average Assets Average over 5 years is $44.1 billion, with a median of $43.7 billion recorded in 2023.
  • The sharpest move saw Assets Average decreased 11.66% in 2021, then decreased 0.59% in 2025.
  • Year by year, Assets Average stood at $47.8 billion in 2021, then decreased by 7.59% to $44.1 billion in 2022, then fell by 3.05% to $42.8 billion in 2023, then dropped by 5.25% to $40.5 billion in 2024, then dropped by 0.59% to $40.3 billion in 2025.
  • Business Quant data shows Assets Average for TEVA at $40.3 billion in Q4 2025, $40.0 billion in Q3 2025, and $39.3 billion in Q2 2025.